peptides storage FAQ

No. 'Multi-dose' refers to the vial's ability to support multiple draws of the same peptide over the 28-day BAC water stability window. It does not authorise adding different compounds. Multi-dose labeling exists to differentiate vials designed for repeated punctures (rubber stopper, preservative-containing solution) from single-use ampules. The term has nothing to do with peptide compatibility or cross-storage safety.

Use a dedicated peptide storage box with individual compartments for each vial, clearly labeled with the peptide name and reconstitution date. Store the box in the main refrigerator compartment (not the door, where temperature fluctuates), and maintain a log tracking puncture count for each vial. If space is limited, prioritise refrigerator real estate for reconstituted peptides and store unopened lyophilised powders at −20°C in a separate freezer compartment. Efficiency comes from organisation, not consolidation.

Discard it. The contamination and degradation variables introduced by mixing cannot be reversed, and continuing to use a compromised solution exposes your research to inconsistent results. Even if the solution appears clear and free of particulates, peptide potency may have degraded by 20–40% within the first week. There is no visual test for peptide stability. HPLC analysis is the only method, and it requires laboratory equipment most researchers do not have access to. Restarting with fresh, individually reconstituted vials eliminates the uncertainty entirely.

Inspect the vial immediately: lyophilized powder should appear as a uniform white or off-white cake at the vial bottom. Clumping, discoloration, or oily residue indicates moisture intrusion or thermal degradation. If the powder looks intact and the vial seal is unbroken, the peptide likely survived. Lyophilized formulations tolerate up to 48 hours at 20–25°C without measurable potency loss, provided they're transferred to -20°C storage immediately upon arrival. For high-value compounds like Cerebrolysin or Dihexa, request a Certificate of Analysis (CoA) from the supplier showing HPLC purity. This baseline lets you verify potency through third-party assay if results seem inconsistent.

Discard it. Once reconstituted, peptides are aqueous solutions vulnerable to the same degradation mechanisms as liquid formulations. And ambient temperature (20–25°C) accelerates hydrolysis by 300–500% compared to refrigeration. Even if the solution appears clear and unchanged, peptide bonds cleave invisibly, reducing bioactivity without visible markers. A single overnight temperature excursion can reduce potency by 40–60%, invalidating any subsequent experimental data. The financial loss of one vial is negligible compared to the research cost of unreliable dosing across an entire study cohort.

Stop using it immediately. Visible particles indicate aggregation, contamination, or precipitate formation, any of which render the peptide unsuitable for research. Aggregated peptides don't simply lose potency; they form insoluble fibrils that can clog syringes, alter pharmacokinetics, and introduce experimental artifacts. Cloudiness can also signal microbial contamination that bacteriostatic agents failed to suppress. Unlike crystalline precipitates (which sometimes form in high-concentration solutions and redissolve with gentle warming), fibrillar aggregates are irreversible. Contact the supplier for a replacement and document the visual appearance with time-stamped photos. Reputable suppliers like Real Peptides replace compromised vials when cold chain failures or manufacturing defects are evident.

If the peptide was at room temperature for more than 4–6 hours, assume potency loss of 15–25% and bacterial growth risk. Refrigerate it immediately and use it within 7 days rather than the full 28-day window. The degradation is time- and temperature-dependent: a 12-hour room-temperature excursion causes significantly more damage than a 2-hour excursion. We've seen researchers attempt to "reset" the 28-day clock by refrigerating after a temperature excursion. This doesn't work. The hydrolysis and oxidation reactions that occurred during the warm period are irreversible.

Use sterile water only for single-dose vials that will be used immediately. Sterile water contains no preservative, so bacterial contamination becomes possible within hours of opening the vial. If you puncture the septum, draw a dose, and leave the vial for a second use, you're working with a potentially contaminated solution. The lack of benzyl alcohol means any bacteria introduced during the first draw will proliferate unchecked. This is acceptable for single-use protocols but unacceptable for multi-dose research where the same vial is accessed repeatedly over days or weeks.

Discard the vial immediately. Cloudiness indicates particulate aggregation or bacterial contamination, both of which render the peptide unsafe and biologically inactive. Aggregation occurs when peptide molecules clump together due to temperature excursions, agitation, or pH shifts during reconstitution. Bacterial contamination appears as cloudiness or visible particles and signals a sterile technique failure at some point in the vial's handling history. Do not attempt to filter, re-dilute, or salvage a cloudy peptide solution. The molecular damage is irreversible.